Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
DomainGABAAa_rcpt

GABRA4 GABRA6

1.22e-046542IPR001390
Domain-

REXO2 EXOSC10 REV3L

3.39e-04475433.30.420.10
DomainRNaseH-like_dom

REXO2 EXOSC10 REV3L

1.05e-0369543IPR012337
DomainGABAA/Glycine_rcpt

GABRA4 GABRA6

2.00e-0323542IPR006028
DomainSerpin_dom

SERPINB7 SERPINA10

4.85e-0336542IPR023796
DomainSERPIN

SERPINB7 SERPINA10

5.12e-0337542SM00093
DomainSERPIN

SERPINB7 SERPINA10

5.12e-0337542PS00284
DomainSerpin

SERPINB7 SERPINA10

5.40e-0338542PF00079
DomainSerpin_fam

SERPINB7 SERPINA10

5.68e-0339542IPR000215
DomainNeurotransmitter_ion_chnl_CS

GABRA4 GABRA6

7.50e-0345542IPR018000
DomainNeur_chan_memb

GABRA4 GABRA6

7.83e-0346542PF02932
DomainNeur_chan_LBD

GABRA4 GABRA6

8.16e-0347542PF02931
DomainNEUROTR_ION_CHANNEL

GABRA4 GABRA6

8.16e-0347542PS00236
DomainNeurotrans-gated_channel_TM

GABRA4 GABRA6

8.16e-0347542IPR006029
Domain-

GABRA4 GABRA6

8.16e-03475422.70.170.10
DomainNeur_channel

GABRA4 GABRA6

8.16e-0347542IPR006201
DomainNeur_chan_lig-bd

GABRA4 GABRA6

8.16e-0347542IPR006202
Pubmed

Stability of the small gamma-tubulin complex requires HCA66, a protein of the centrosome and the nucleolus.

UTP6 TUBGCP3

1.42e-05454219299467
Pubmed

A severe diabetic nephropathy model with early development of nodule-like lesions induced by megsin overexpression in RAGE/iNOS transgenic mice.

MOK SERPINB7

1.42e-05454216443768
Pubmed

GABAA receptor signaling in caudal periaqueductal gray regulates maternal aggression and maternal care in mice.

GABRA4 GABRA6

3.54e-05654220457185
Pubmed

gamma-Aminobutyric acidA receptors displaying association of gamma 3-subunits with beta 2/3 and different alpha-subunits exhibit unique pharmacological properties.

GABRA4 GABRA6

6.59e-0585428175718
Pubmed

Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.

SERPINB7 TRPC4AP AFF2 ARHGEF12 MSH4 PLD1 GABRA4

8.92e-0568654729987050
Pubmed

R2TP/Prefoldin-like component RUVBL1/RUVBL2 directly interacts with ZNHIT2 to regulate assembly of U5 small nuclear ribonucleoprotein.

CLPTM1L TBC1D7 TUBGCP3 DYRK1A INO80

1.03e-0430054528561026
Pubmed

Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women.

SRGAP1 RIPK4

1.06e-041054225134534
Pubmed

Review: Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis.

GABRA4 GABRA6

1.29e-04115429924185
Pubmed

Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.

SERPINB7 ZNF384 TBC1D7 TUBGCP3 NIPAL2 REV3L LRRC8D ZEB2 RYR1

1.55e-04129354915342556
Pubmed

RhoG signals in parallel with Rac1 and Cdc42.

ARHGEF12 PLD1

1.83e-041354212376551
Pubmed

Neurotransmitter-mediated action of an antagonist of growth hormone-releasing hormone on anxiolysis in mice.

GABRA4 GABRA6

1.83e-041354222569571
Pubmed

Involvement of neurotransmitters in the action of growth hormone-releasing hormone antagonist on passive avoidance learning.

GABRA4 GABRA6

1.83e-041354222640814
Pubmed

Characterization of long cDNA clones from human adult spleen. II. The complete sequences of 81 cDNA clones.

DNHD1 TRPC4AP

3.17e-041754212693554
Pubmed

Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype.

GABRA4 GABRA6

3.56e-041854219078961
Pubmed

Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.

CLPTM1L CENPE

3.98e-041954223666240
Pubmed

Collagen VI suppresses fibronectin-induced enteric neural crest cell migration by downregulation of focal adhesion proteins.

MYH11 ZEB2

3.98e-041954229196262
Pubmed

Defining the membrane proteome of NK cells.

CLPTM1L EXOSC10 CENPE TUBGCP3 PSMD12 PLD1 LRRC8D ADCY3

4.17e-04116854819946888
Pubmed

Early growth response 1 (Egr-1) directly regulates GABAA receptor α2, α4, and θ subunits in the hippocampus.

GABRA4 GABRA6

4.88e-042154225708312
Pubmed

Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.

USP34 ADCY3 ZEB2

5.93e-041055439628581
Pubmed

PEA15 regulates the DNA damage-induced cell cycle checkpoint and oncogene-directed transformation.

DYRK1A PLD1

6.39e-042454224710276
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

USP34 PDE7A IFT172 DYRK1A RIPK4 MORC3 REV3L ZEB2

7.80e-04128554835914814
Pubmed

Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.

EXOSC10 IFT172 TUBGCP3 ARHGEF12 INO80

8.48e-0447554531040226
Pubmed

Non-trisomic homeobox gene expression during craniofacial development in the Ts65Dn mouse model of Down syndrome.

DYRK1A RIPK4

9.35e-042954223843306
Pubmed

Use of comparative physical and sequence mapping to annotate mouse chromosome 16 and human chromosome 21.

DYRK1A MORC3

1.00e-033054211374901
Pubmed

Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.

USP34 LGMN EXOSC10 DYRK1A PLD1 INO80 ADCY3

1.38e-03108454711544199
Cytoband21q22.13

DYRK1A MORC3

1.61e-041654221q22.13
CytobandEnsembl 112 genes in cytogenetic band chr4p12

CORIN GABRA4

4.33e-0426542chr4p12
GeneFamilyGamma-aminobutyric acid type A receptor subunits

GABRA4 GABRA6

8.37e-0419412563
ToppCellPND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MPP2 MYH11 AFF2 CORIN ADCY3 ZEB2

1.37e-071965466708026bafd19c35c5c4e81911344d36a0f508cd
ToppCelldroplet-Marrow-nan-21m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AFF2 DGAT2 SERPINA10 RYR1 B4GALT5

2.03e-06171545355a27ea88410a84210f7e4298c7c4f90cf2f8a9
ToppCellChildren_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

LGMN CALCR SRGAP1 ZEB2 RYR1

2.99e-061855458207f9eff113eed429e961748c6b17d672a13b33
ToppCellChildren_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor

LGMN CALCR SRGAP1 ZEB2 RYR1

3.41e-06190545f573fef3762a30c38cf8fa7f45df0ffbb49dc873
ToppCellChildren_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

LGMN CALCR SRGAP1 ZEB2 RYR1

3.41e-061905452d54fca50593fbd11fe13fc2bfaf937a05db776d
ToppCellControl-Myeloid-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations)

LGMN CALCR SRGAP1 ZEB2 RYR1

3.68e-06193545a6b3bd01e585e2e3fbe9bf693a2e385773123f8e
ToppCellParenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

LGMN CALCR SRGAP1 ZEB2 RYR1

4.37e-06200545179afc4bee7a2fd85a3b5dadf32544a63807c164
ToppCellParenchymal-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

LGMN CALCR SRGAP1 ZEB2 RYR1

4.37e-06200545ad52b38df5c71f28829b04cd0e6b97f0f9f7610a
ToppCellfacs-Lung-Endomucin-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MPP2 MYH11 AFF2 SERPINA10

5.25e-051695442d23b4cee060f8adddc430c1c10d4e25205b4af6
ToppCellfacs-Lung-Endomucin-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MPP2 MYH11 AFF2 SERPINA10

5.25e-05169544ecaf08e8e0b54d1c97a02bc1f65409fd43d68227
ToppCellfacs-Lung-Endomucin-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MPP2 MYH11 AFF2 SERPINA10

5.25e-05169544ad6af6609acf158cb79e45ee7ca9af332be3c40c
ToppCelldroplet-Thymus-nan-21m-Myeloid-professional_antigen_presenting_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LGMN ZEB2 RYR1 GABRA4

5.37e-0517054429deb285d5a82c0abcc108012ca42f4b4b4d9e19
ToppCelldroplet-Thymus-nan-21m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LGMN ZEB2 RYR1 GABRA4

5.37e-05170544dc35d66a9a9fe6cdd7f4ec0fe7efa49d02f2b5b2
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MYH11 NIPAL2 PLD1 ADCY3

5.37e-0517054499dd734c0972a40d5381e8e2d96bdaa31f6d06e6
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MYH11 NIPAL2 PLD1 ADCY3

5.37e-051705443a14eeae221b8bb0bd0dadcb8e7a603431240a1e
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MYH11 NIPAL2 PLD1 ADCY3

5.37e-05170544cdb6fad277f284c3fd5a6f45672a8edc24715882
ToppCellE16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MYH11 CENPE CORIN ADCY3

5.88e-051745447fb7bdf62563f2102fb38618b503eb2817b6594f
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MYH11 AFF2 ADCY3 ZEB2

6.28e-051775444943d040eee0f9dceaddc7498171281d170e271f
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MYH11 AFF2 ADCY3 ZEB2

6.28e-051775443f2272b577c862dba8ccfb41184054bbd0ace6f5
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MYH11 AFF2 ADCY3 ZEB2

6.28e-05177544a8625d14682183cf77cb51eaf11bc15a3528f586
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MYH11 AFF2 ADCY3 ZEB2

6.28e-051775443645e2f4a48283f290f85c49c3e79e3f58ac9aa6
ToppCellPND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

OLFML2A MYH11 CORIN ADCY3

7.15e-051835444060d979948e1dd7507977629a7fbdfa4ca65bb6
ToppCellPND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

OLFML2A MYH11 CORIN ADCY3

7.15e-051835440d44a978221cf3f733704bf11863502805fba733
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)

OLFML2A LGMN ZNF384 CLPTM1L

7.30e-05184544af6522586d012e91241f3e06c60f9d1881e95646
ToppCelldroplet-Marrow-nan-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LGMN REXO2 RYR1 GABRA4

7.45e-05185544238938a4682b44e88a30b86b13af4feeabe9553d
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MYH11 AFF2 ADCY3 ZEB2

7.77e-05187544ec4b694487cc446999c7b27b119950a4f252c4b3
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

MYH11 AFF2 ADCY3 ZEB2

7.77e-0518754448bfdb3504c3fefe5db3abac4b790c369680ab4e
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MYH11 AFF2 ADCY3 ZEB2

7.77e-05187544530e4e6d91b5c0d9aa4543caa2b734a1674c5788
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

MYH11 AFF2 ADCY3 ZEB2

7.77e-05187544958402fcc78f4c7a7d13d659d776f3817137975f
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MYH11 AFF2 ADCY3 ZEB2

7.93e-05188544b2d68a32314e9b099ed74d974079ad96359d1ae3
ToppCell5'-Adult-Distal_Rectal-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ZNF384 DGAT2 TUBGCP3 ZEB2

8.10e-051895449e3c083174a64ea78648c6d48498fc4e721b569f
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

MYH11 AFF2 ADCY3 ZEB2

8.10e-05189544fac5c291a9a87418bb0878c3d624829bdbf1f428
ToppCell5'-Adult-Distal_Rectal-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ZNF384 DGAT2 TUBGCP3 ZEB2

8.10e-051895446e19bfa52406ebe095daa99f958ec4d596ce6e39
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

OLFML2A MYH11 AFF2 ARHGEF12

8.26e-0519054410125091ad648163777b02e9f0d5e8d7f17d44a5
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MYH11 AFF2 ADCY3 ZEB2

8.26e-051905445681c211baeed4af82a2bbc13420f6a7b487581c
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MYH11 AFF2 ADCY3 ZEB2

8.60e-0519254424e2f15f5767a97eb3b389922bcfd7b13805e1ce
ToppCell5'-Adult-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LGMN SRGAP1 ZEB2 RYR1

8.95e-051945447c7091de47359760003e910cfbe63db5c99410d6
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

OLFML2A CENPE ARHGEF12 MMRN2

8.95e-0519454478dcb9d48259afabe73b41c5508a73a8d62339a4
ToppCellPND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MPP2 MYH11 AFF2 ZEB2

9.13e-051955444a5d2f62aad5817d077177bf8b4ff0e46d3b8d97
ToppCellPND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MPP2 MYH11 AFF2 ZEB2

9.13e-051955447a32a8535c29b819dacba901d0658280a2631c94
ToppCelldroplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LGMN MMRN2 NIPAL2 CORIN

9.32e-051965447d5eaed189aa6116f3799be010139fb675ec65e0
ToppCelldroplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LGMN MMRN2 NIPAL2 CORIN

9.32e-05196544dbf154b3d166ffd07be717dac8d8a3350ac63e16
ToppCellBronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

LGMN SRGAP1 ZEB2 RYR1

9.69e-05198544c7dbf24caae5c4ef285845d13055de9e07281bb3
ToppCellParenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_CCL|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

CALCR DGAT2 TBC1D7 ZEB2

9.88e-0519954452c06fcc112da21b1d914a896c04bde06fc756fe
ToppCellFetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type.

ZNF384 TUBGCP3 DYRK1A ADCY3

9.88e-05199544fd1d1b95e01719e3d0a17d9d1f29717a47209d32
ToppCellFetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type.

ZNF384 TUBGCP3 DYRK1A ADCY3

9.88e-0519954491882af9dc7265c9b419f4415cbcf656087a2ab3
DrugMidazolam

CYP1A1 GABRA4 GABRA6

2.64e-0525533ctd:D008874
Drugetazolate

ADCY3 GABRA4 GABRA6

4.17e-0529533CID000003277
Drugdiphenyl ether

CYP1A1 REXO2 RIPK4

5.11e-0531533CID000007583
DrugMeprobamate

GABRA4 GABRA6

7.93e-056532DB00371
DrugFlunitrazepam

GABRA4 GABRA6

7.93e-056532DB01544
DrugKynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A

OLFML2A CALCR DYRK1A ARHGEF12 RYR1

9.44e-051975355276_UP
DrugFlumequine [42835-25-6]; Down 200; 15.4uM; HL60; HG-U133A

USP34 TUBGCP3 MORC3 REV3L ZEB2

9.44e-051975351429_DN
DrugTrioxsalen [3902-71-4]; Down 200; 17.6uM; MCF7; HT_HG-U133A

MPP2 MOK OLFML2A TUBGCP3 NIPAL2

9.44e-051975356078_DN
DrugChlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A

MPP2 MOK TRPC4AP NIPAL2 ADCY3

9.44e-051975355493_DN
DrugAdenosine 5'-monophosphate monohydrate [18422-05-4]; Up 200; 11uM; MCF7; HT_HG-U133A

OLFML2A MYH11 AFF2 DYRK1A ADCY3

9.67e-051985353237_UP
DrugBacitracin [1405-87-4]; Down 200; 2.8uM; MCF7; HT_HG-U133A

MOK CYP1A1 USP34 ARHGEF12 NIPAL2

9.67e-051985356488_DN
Drugsevoflurane

LGMN RYR1 GABRA4 GABRA6

1.05e-04105534CID000005206
Drugendrine

CYP1A1 ADCY3 GABRA4 GABRA6

1.09e-04106534CID000003048
Drugzolpidem

AFF2 GABRA4 GABRA6

1.38e-0443533CID000005732
DrugRo 5-4864

ZNF384 GABRA4 GABRA6

1.47e-0444533CID000001688
DrugRo 15-4513

GABRA4 GABRA6

1.48e-048532ctd:C042957
DrugS-[2-[3-[[(2R)-4-[[[(2R,3R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] (3S)-3-hydroxy-3-methyl-5-oxohexanethioate

DGAT2 RYR1

1.48e-048532CID016061173
DrugFlumazenil

GABRA4 GABRA6

1.48e-048532ctd:D005442
DrugTPMPA

EXOSC10 GABRA4 GABRA6

1.58e-0445533CID000005520
Drugthymol

RYR1 GABRA4 GABRA6

1.68e-0446533CID000006989
DrugEthchlorvynol

GABRA4 GABRA6

1.89e-049532DB00189
Drugpentachlorobiphenyl

CYP1A1 RYR1

1.89e-049532CID000017348
Drugfelbamate

CYP1A1 GABRA4 GABRA6

1.91e-0448533ctd:C047360
Drugacyclovir

TDRD7 AFF2 REV3L ADCY3

2.00e-04124534CID000002022
DrugSecobarbital

GABRA4 GABRA6

2.36e-0410532DB00418
DrugChlordiazepoxide

GABRA4 GABRA6

2.36e-0410532DB00475
DrugMetharbital

GABRA4 GABRA6

2.36e-0410532DB00463
DrugPentobarbital

GABRA4 GABRA6

2.36e-0410532DB00312
DrugTalbutal

GABRA4 GABRA6

2.36e-0410532DB00306
DrugClobazam

GABRA4 GABRA6

2.36e-0410532DB00349
DrugButalbital

GABRA4 GABRA6

2.36e-0410532DB00241
DrugButabarbital

GABRA4 GABRA6

2.36e-0410532DB00237
DrugBromazepam

GABRA4 GABRA6

2.36e-0410532DB01558
DrugBarbituric acid derivative

GABRA4 GABRA6

2.36e-0410532DB01496
DrugBarbital

GABRA4 GABRA6

2.36e-0410532DB01483
DrugHexobarbital

GABRA4 GABRA6

2.36e-0410532DB01355
DrugAprobarbital

GABRA4 GABRA6

2.36e-0410532DB01352
DrugAmobarbital

GABRA4 GABRA6

2.36e-0410532DB01351
DrugHeptabarbital

GABRA4 GABRA6

2.36e-0410532DB01354
DrugButethal

GABRA4 GABRA6

2.36e-0410532DB01353
DrugAC1L1FKW

GABRA4 GABRA6

2.36e-0410532CID000003281
DrugPCB 95

CYP1A1 RYR1

2.36e-0410532CID000038012
DrugMethylphenobarbital

GABRA4 GABRA6

2.36e-0410532DB00849
DrugOxazepam

GABRA4 GABRA6

2.36e-0410532DB00842
DrugPrimidone

GABRA4 GABRA6

2.36e-0410532DB00794
DrugMidazolam

GABRA4 GABRA6

2.36e-0410532DB00683
DrugFlurazepam

GABRA4 GABRA6

2.36e-0410532DB00690
DrugThiopental

GABRA4 GABRA6

2.89e-0411532DB00599
DrugAlprazolam

GABRA4 GABRA6

2.89e-0411532DB00404
Drugfosazepam

GABRA4 GABRA6

2.89e-0411532CID000037114
DrugC19H18ClN3O

GABRA4 GABRA6

2.89e-0411532CID000027452
Drugflutoprazepam

GABRA4 GABRA6

2.89e-0411532CID000003400
DrugArfendazam

GABRA4 GABRA6

2.89e-0411532CID000065803
DrugTemazepam

GABRA4 GABRA6

2.89e-0411532DB00231
DrugNitrazepam

GABRA4 GABRA6

2.89e-0411532DB01595
DrugLorazepam

GABRA4 GABRA6

2.89e-0411532DB00186
Drugcamazepam

GABRA4 GABRA6

2.89e-0411532CID000037367
DrugPhenobarbital

GABRA4 GABRA6

2.89e-0411532DB01174
Drugtriflubazam

GABRA4 GABRA6

2.89e-0411532CID000031157
DrugBu-1014

GABRA4 GABRA6

2.89e-0411532CID015942721
DrugZapizolam

GABRA4 GABRA6

2.89e-0411532CID000068832
DrugReclazepam

GABRA4 GABRA6

2.89e-0411532CID003052777
Drugiclazepam

GABRA4 GABRA6

2.89e-0411532CID000068777
Drugmenitrazepam

GABRA4 GABRA6

2.89e-0411532CID000189875
DrugMelanins

CYP1A1 PLD1

2.89e-0411532ctd:D008543
DrugTriazolam

GABRA4 GABRA6

2.89e-0411532DB00897
DrugSerin hydrazid

GABRA4 GABRA6

2.89e-0411532CID000041637
Drugsulazepam

GABRA4 GABRA6

2.89e-0411532CID000017931
Drugelfazepam

GABRA4 GABRA6

2.89e-0411532CID000065445
DrugClorazepate

GABRA4 GABRA6

2.89e-0411532DB00628
Druguldazepam

GABRA4 GABRA6

2.89e-0411532CID000034274
Druggidazepam

GABRA4 GABRA6

2.89e-0411532CID000121919
Drugfletazepam

GABRA4 GABRA6

2.89e-0411532CID000036834
DrugK-Cl

MOK MYH11 PLD1 REV3L ADCY3 ZEB2 RYR1

3.27e-04567537CID000004873
DrugSB-205384

GABRA4 GABRA6

3.46e-0412532CID000197690
DrugU-93631

GABRA4 GABRA6

3.46e-0412532CID000197626
Drughaloxazolam

GABRA4 GABRA6

3.46e-0412532CID000003563
Drugpivoxazepam

GABRA4 GABRA6

3.46e-0412532CID000068722
Drugdoxefazepam

GABRA4 GABRA6

3.46e-0412532CID000038668
Drug2,4,6-tribromoanisole

CYP1A1 RYR1

3.46e-0412532CID000011839
Drugrazobazam

GABRA4 GABRA6

3.46e-0412532CID000071228
Drugflunitrazepam

LGMN GABRA4 GABRA6

3.53e-0459533CID000003380
Drugketamine

CYP1A1 LGMN RYR1 GABRA4 GABRA6

3.55e-04262535CID000003821
DrugAC1MVFYM

GABRA4 GABRA6

4.08e-0413532CID003707225
Drugnerisopam

GABRA4 GABRA6

4.08e-0413532CID000065875
DrugRo 11-3128

GABRA4 GABRA6

4.08e-0413532CID000093364
Drugcinolazepam

GABRA4 GABRA6

4.08e-0413532CID003033621
Drugflutazolam

GABRA4 GABRA6

4.08e-0413532CID000003398
Drugalpha IMGBL

GABRA4 GABRA6

4.08e-0413532CID000131516
Drug4-PIOL

GABRA4 GABRA6

4.08e-0413532CID000125520
Drugmetaclazepam

GABRA4 GABRA6

4.08e-0413532CID000071272
Druggamma-Aminobutyric Acid

CALCR GABRA4 GABRA6

4.09e-0462533ctd:D005680
Diseasebasophil percentage of leukocytes

REXO2 AFF2 DYRK1A RYR1

8.28e-04243514EFO_0007992
Diseaseeosinophil measurement

USP34 LGMN DYRK1A

8.74e-04108513EFO_0803540
Diseaseoral squamous cell carcinoma (is_implicated_in)

CYP1A1 CLPTM1L

1.08e-0328512DOID:0050866 (is_implicated_in)
Diseasewaist-hip ratio

TDRD7 MPP2 OLFML2A MYH11 CALCR PSMD12 PLD1 ADCY3

1.13e-031226518EFO_0004343
DiseaseMiddle Cerebral Artery Embolus

PLD1 GABRA6

1.59e-0334512C0751845
DiseaseEmbolic Infarction, Middle Cerebral Artery

PLD1 GABRA6

1.59e-0334512C0751847
DiseaseLeft Middle Cerebral Artery Infarction

PLD1 GABRA6

1.59e-0334512C0751846
DiseaseRight Middle Cerebral Artery Infarction

PLD1 GABRA6

1.59e-0334512C0751849
DiseaseThrombotic Infarction, Middle Cerebral Artery

PLD1 GABRA6

1.59e-0334512C0751848
DiseaseMiddle Cerebral Artery Occlusion

PLD1 GABRA6

1.59e-0334512C0740391
DiseaseInfarction, Middle Cerebral Artery

PLD1 GABRA6

1.59e-0334512C0740392
DiseaseMiddle Cerebral Artery Thrombosis

PLD1 GABRA6

1.59e-0334512C0740376
DiseaseMiddle Cerebral Artery Syndrome

PLD1 GABRA6

1.59e-0334512C0238281

Protein segments in the cluster

PeptideGeneStartEntry
MLILYAKMKKFTYII

ERICH6B

506

Q5W0A0
KMLGKIYDYVMHSLI

CALCR

366

P30988
DHAMKYSRSLMEYFK

AFF2

1176

P51816
MTALKMERYLKKIHF

DNHD1

281

Q96M86
EMKYYIVHLKRHFMF

DYRK1A

216

Q13627
MPRHFATKLDKYMYL

B4GALT5

251

O43286
YVILMYMKHLGVKVK

ARHGEF12

546

Q9NZN5
HSKYKTYMCRDMKQR

RC3H1

411

Q5TC82
EKFYSFMQKMVKEHY

CYP1A1

256

P04798
DLLEEYMVYRKHTYM

INO80

1131

Q9ULG1
KVMYRMAHKPVYQVK

MMRN2

96

Q9H8L6
MMYHRNRLIKAYEKV

MORC3

316

Q14149
ERSLHKPMYYFLSML

OR51F2

66

Q8NH61
YFHLDMMKLRRFLVM

PDE7A

186

Q13946
KVHELMKRLMYFAYT

MRGPRD

96

Q8TDS7
HLRRKMGYFMIQTYI

GABRA4

251

P48169
EYVIMTVYFHLQRKM

GABRA6

226

Q16445
KKYSLLDHMQAMRRY

TUBGCP3

551

Q96CW5
MKYMLKYFGAHERLE

MPP2

66

Q14168
RRYPLSEKKIMHYMY

MOK

96

Q9UQ07
HNIRIMAKYYTRITM

PSMD12

361

O00232
MYKKHKLYDDMIRLV

IFT172

1006

Q9UG01
LDKYMPQFMKHLHYR

REXO2

151

Q9Y3B8
THYLLYIYDKMRLEM

EXOSC10

441

Q01780
KHFMTGYRVIFYIMV

GLT6D1

101

Q7Z4J2
IMSYYMADRKHRKAF

ADCY3

241

O60266
MEMEKFLKFFTYLHR

CORIN

166

Q9Y5Q5
KKLLYQYEAMMHLKR

DRC7

666

Q8IY82
HAMAFYVVKMYKHLK

MALSU1

136

Q96EH3
LAHKKYDPELYRMAM

RYR1

2686

P21817
RCSMEFHRIMKKLKY

CENPE

2161

Q02224
MYMEALVKLFDKHKT

DGAT2

361

Q96PD7
HNMAYMLKKLLISYI

LRRC8D

356

Q7L1W4
KMLYPEYHKVHQMMR

OSGIN1

331

Q9UJX0
YSMDLMKVHAYVHKV

OLFML2A

131

Q68BL7
PKLYKEYFRMELMHA

UTP6

176

Q9NYH9
TMKRQIKHMIKYRYI

RER1

161

O15258
KVLNELYTVMKTYHM

SRGAP1

156

Q7Z6B7
IMHEIMYKLEVLYVL

TRPC4AP

381

Q8TEL6
YLTKILKMPMYRNYH

PLD1

186

Q13393
LLYFYKRKGMKHMVI

NIPAL2

196

Q9H841
REIYHMTYMIVCKLL

MSH4

586

O15457
HKLEVLMEEMILYYS

TDRD7

936

Q8NHU6
KVMMYRKEQYLDVLH

TBC1D7

76

Q9P0N9
KKMEMAKFRYILPVY

RIPK4

71

P57078
RYMKMIQLGKTVHYL

CLPTM1L

196

Q96KA5
FHIFYYMIAGAKEKM

MYH11

281

P35749
AYTSETYLMKHMRKH

ZNF384

441

Q8TF68
HFMKIYLYNPTMVKR

REV3L

121

O60673
LYISRMMHKSYIEVT

SERPINB7

316

O75635
FHLDKYKTIKVPMMY

SERPINA10

256

Q9UK55
EKTHSAYMLFYKRME

USP34

2226

Q70CQ2
PYKDHMSVLKAYYAM

ZEB2

651

O60315
LNETIHYMYKHKMYR

LGMN

166

Q99538
HKMYRKMVFYIEACE

LGMN

176

Q99538